Oklahoma Medical Research Foundation

Oklahoma City, Oklahoma 73113

11 studies enrolling now · 119 studies all time

What they study most

Active Systemic Lupus Erythematosus, Adrenocortical Carcinoma, Aging, Aging Well, Antiphospholipid Syndrome, Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Central Neuropathic Pain

Studies at this site

• Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX) — Recruiting now
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis — Recruiting now
• A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) — Recruiting now
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease — Recruiting now
• A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — Recruiting now
• Muscle Recovery After Critical Illness — Recruiting now
• Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) — Recruiting now
• Skeletal Muscle Aging and Responsiveness in Aged People With MS — Recruiting now
• A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132 — Recruiting now
• Safety of the Herpes Zoster Subunit Vaccine in Lupus — Recruiting now
• Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial — Recruiting now
• A Study of Obexelimab in Patients With Systemic Lupus Erythematosus — Recruiting now
• Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD — Recruiting now
• Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis — Completed
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) — Completed
• Study of Anti-Malarials in Incomplete Lupus Erythematosus — Completed
• Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease. — Stopped early
• Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus — Stopped early
• Next-Gen MS: Feed-forward PRO Data for MS Research — Stopped early
• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) — Completed
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma — Completed
• Combination Chemotherapy in Treating Women With Breast Cancer — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE — Status unconfirmed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed
• Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis — Stopped early
• Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches — Completed
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• Functional Intermuscular Reduction of Spasticity — Completed
• Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis — Completed
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) — Stopped early
• A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
• Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed — Completed
• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. — Completed
• Safety of Zostavax Vaccination in Rheumatoid Arthritis — Completed
• Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus — Stopped early
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus — Completed
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early